Filing Details

Accession Number:
0001209191-22-019276
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-16 17:01:49
Reporting Period:
2022-03-15
Accepted Time:
2022-03-16 17:01:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891024 Patterson Companies Inc. PDCO Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047) 410886515
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1652545 B Les Korsh 1031 Mendota Heights Road
St. Paul MN 55120
Vp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-03-15 6,000 $30.91 83,486 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,976 Indirect By ESOP
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Employee Stock Options $30.77 2031-07-01 17,339 17,339 Direct
Common Stock Employee Stock Options $23.57 2030-07-14 24,780 24,780 Direct
Common Stock Employee Stock Options $22.25 2029-07-01 33,784 33,784 Direct
Common Stock Employee Stock Options $22.48 2021-07-01 2028-07-01 14,179 14,179 Direct
Common Stock Employee Stock Options $47.51 2020-07-01 2027-07-01 11,845 11,845 Direct
Common Stock Employee Stock Options $48.47 2019-07-01 2026-07-01 10,379 10,379 Direct
Common Stock Employee Stock Options $56.66 2025-07-01 25,000 25,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2031-07-01 17,339 17,339 Direct
2030-07-14 24,780 24,780 Direct
2029-07-01 33,784 33,784 Direct
2028-07-01 14,179 14,179 Direct
2027-07-01 11,845 11,845 Direct
2026-07-01 10,379 10,379 Direct
2025-07-01 25,000 25,000 Direct
Footnotes
  1. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on December 8, 2021.
  2. Includes an aggregate of 16,637 RSUs awarded on 7/1/2017, 7/1/2018, 7/1/2019, 7/14/2020 and 7/1/2021 to Reporting Person pursuant to the Plan. The RSUs vest contingent upon continued employment as follows: 7,938 units vest on 7/1/2022, 2,436 units vest on 7/1/2023, 4,773 units vest on 7/14/2023 and 1,490 units vest on 7/1/2024.
  3. Includes 14,410 RSU equivalents attributable to the July 1, 2020 determination by the Compensation Committee that the performance criteria for the period of April 27, 2019 through April 25, 2020 applicable to non-derivative performance units issued on July 1, 2019 had been satisfied. Subject to continued employment of the Reporting Person through July 1, 2022, the RSU equivalents will automatically convert into shares of common stock.
  4. Represents shares of common stock indirectly held by the Reporting Person's Employee Stock Ownership Plan (ESOP) account through May 21, 2021.
  5. Stock options granted pursuant to the Plan on 7/1/2021.
  6. Options are exercisable as follows: 33.3% on 7/1/2022, 33.3% on 7/1/2023 and 33.4% on 7/1/2024.
  7. Stock options granted pursuant to the Plan on 7/14/2020.
  8. Options are exercisable as follows: 33.3% on 7/14/2021, 33.3% on 7/14/2022 and 33.4% on 7/14/2023.
  9. Stock options granted pursuant to the Plan on 7/1/2019.
  10. Options are exercisable as follows: 33.3% on 7/1/2020, 33.3% on 7/1/2021 and 33.4% on 7/1/2022.
  11. Stock options granted pursuant to the Plan on 7/1/2018.
  12. Stock options granted pursuant to the Plan on 7/1/2017.
  13. Stock options granted pursuant to the Plan on 7/1/2016.
  14. Stock options granted pursuant to the Patterson Companies, Inc. Amended and Restated Equity Incentive Plan on 7/1/2015.
  15. Options are exercisable as follows: 25% on 7/1/2018, 25% on 7/1/2019 and 50% on 7/1/2020.